Transmission of Human Immunodeficiency Virus and Hepatitis C Virus Through Liver Transplantation

被引:54
作者
Ahn, Joseph [1 ]
Cohen, Stanley M. [1 ]
机构
[1] Rush Univ, Med Ctr, Sect Hepatol, Chicago, IL 60612 USA
关键词
D O I
10.1002/lt.21534
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In November 2007, a liver transplant recipient was confirmed to have human immunodeficiency virus (HIV) and hepatitis C (HCV) infection after the organ procurement agency notified our institution that the donor has been HIV and HCV positive. We reviewed medical records and the collected blood sample results for HIV and HCV testing. A 66 year old female with nonalcoholic steatohepatitis cirrhosis underwent liver transplantation. The donor was a male who had sex with men who received multiple blood transfusions during resuscitation. Preoperative testing for HIV and HCV antibodies were negative for both donor and recipient. Ten months later, HIV and HCV were identified with nucleic acid testing in the recipient and in the stored donor sera. This is the first reported case of HIV transmission from solid organ transplantation in 20 years, and the first ever reported case of simultaneously transmitted HIV and HCV. The current case represents a high risk donor with newly-acquired HIV and HCV who transmitted the diseases during the window period of the infections. In this era of organ shortages one option would be avoidance of any high-risk donor organs. Another option would be to continue the use of such organs with appropriate informed consent, acknowledging the limitations of current screening tests for HIV and HCV. This report should serve as a wake-up call to the transplant community to consider revamping organ donor screening for HIV and HCV using nucleic acid testing as well as reconsidering the ongoing use of high-risk donors. Liver Transpi 14:1603-1608, 2008. (C) 2008 AASLD.
引用
收藏
页码:1603 / 1608
页数:6
相关论文
共 30 条
[1]  
[Anonymous], 1994, MMWR Recomm Rep, V43, P1
[2]  
[Anonymous], ORGAN PROCUREMENT TR
[3]   A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors [J].
Busch, MP ;
Glynn, SA ;
Stramer, SL ;
Strong, DM ;
Caglioti, S ;
Wright, DJ ;
Pappalardo, B ;
Kleinman, SH .
TRANSFUSION, 2005, 45 (02) :254-264
[4]   TIME-COURSE OF DETECTION OF VIRAL AND SEROLOGIC MARKERS PRECEDING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION - IMPLICATIONS FOR SCREENING OF BLOOD AND TISSUE DONORS [J].
BUSCH, MP ;
LEE, LLL ;
SATTEN, GA ;
HENRARD, DR ;
FARZADEGAN, H ;
NELSON, KE ;
READ, S ;
DODD, RY ;
PETERSEN, LR .
TRANSFUSION, 1995, 35 (02) :91-97
[5]  
*CDC, 1987, MMWR-MORBID MORTAL W, V36, P306
[6]  
*CDC, 2001, MMWR-MORBID MORTAL W, V51, P273
[7]  
*CDC, 1985, MMWR-MORBID MORTAL W, V34, P294
[8]   Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population [J].
Dodd, RY ;
Notari, EP ;
Stramer, SL .
TRANSFUSION, 2002, 42 (08) :975-979
[9]   Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus [J].
Duclos-Vallee, Jean-Charles ;
Feray, Cyrille ;
Sebagh, Mylene ;
Teicher, Elina ;
Roque-Afonso, Anne-Marie ;
Roche, Bruno ;
Azoulay, Daniel ;
Adam, Rene ;
Bismuth, Henri ;
Castaing, Denis ;
Vittecoq, Daniel ;
Satnuel, Didier .
HEPATOLOGY, 2008, 47 (02) :407-417
[10]   Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection [J].
Fiebig, EW ;
Wright, DJ ;
Rawal, BD ;
Garrett, PE ;
Schumacher, RT ;
Peddada, L ;
Heldebrant, C ;
Smith, R ;
Conrad, A ;
Kleinman, SH ;
Busch, MP .
AIDS, 2003, 17 (13) :1871-1879